The implication of coronary artery calcium testing for cardiovascular disease prevention and diabetes

Endocrinology and Metabolism

Volumn 32, Issue 1, 2017, Pages 47-57

  Blankstein, Ron ^a,b   Gupta, Ankur ^a,b   Rana, Jamal S ^c,d   Nasir, Khurram ^e,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c KAISER PERMANENTE   (United States)

^d DIVISION OF RESEARCH   (United States)

^e FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^f BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

Author keywords

Atherosclerosis; Coronary artery disease; Diabetes; Prevention and control

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; DIABETES MELLITUS; DISEASE SEVERITY; DRUG INDICATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; PRACTICE GUIDELINE; PRIMARY PREVENTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT;

EID: 85015874159     PISSN: 2093596X     EISSN: 20935978     Source Type: Journal    
DOI: 10.3803/EnM.2017.32.1.47     Document Type: Review

References (45)

1. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008;358:1336-45.
2. Blaha MJ, Budoff MJ, DeFilippis AP, Blankstein R, Rivera JJ, Agatston A, et al. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet 2011;378:684-92.
3. Blankstein R, Budoff MJ, Shaw LJ, Goff DC Jr, Polak JF, Lima J, et al. Predictors of coronary heart disease events among asymptomatic persons with low low-density lipoprotein cholesterol MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2011;58:364-74.
4. Silverman MG, Blaha MJ, Krumholz HM, Budoff MJ, Blankstein R, Sibley CT, et al. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis. Eur Heart J 2014;35:2232-41.
5. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010;303:1610-6.
6. Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 2012;308:788-95.
7. Kavousi M, Elias-Smale S, Rutten JH, Leening MJ, Vliegenthart R, Verwoert GC, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med 2012;156:438-44.
8. Rana JS, Gransar H, Wong ND, Shaw L, Pencina M, Nasir K, et al. Comparative value of coronary artery calcium and multiple blood biomarkers for prognostication of cardiovascular events. Am J Cardiol 2012;109:1449-53.
9. Sarwar A, Shaw LJ, Shapiro MD, Blankstein R, Hoffmann U, Cury RC, et al. Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging 2009;2:675-88.
10. Blaha MJ, Cainzos-Achirica M, Greenland P, McEvoy JW, Blankstein R, Budoff MJ, et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2016;133:849-58.
11. Tota-Maharaj R, Blaha MJ, McEvoy JW, Blumenthal RS, Muse ED, Budoff MJ, et al. Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old. Eur Heart J 2012;33:2955-62.
12. Blankstein R, Foody JM. Screening for coronary artery disease in patients with family history. how, when, and in whom? Circ Cardiovasc Imaging 2014;7:417-9.
13. Nasir K, Bittencourt MS, Blaha MJ, Blankstein R, Agatson AS, Rivera JJ, et al. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2015;66:1657-68.
14. Mahabadi AA, Mohlenkamp S, Lehmann N, Kalsch H, Dykun I, Pundt N, et al. CAC score improves coronary and CV risk assessment above statin indication by ESC and AHA/ACC primary prevention guidelines. JACC Cardio vasc Imaging 2017;10:143-53.
15. Messenger B, Li D, Nasir K, Carr JJ, Blankstein R, Budoff MJ. Coronary calcium scans and radiation exposure in the multi-ethnic study of atherosclerosis. Int J Cardiovasc Imaging 2016;32:525-9.
16. Miedema MD, Duprez DA, Misialek JR, Blaha MJ, Nasir K, Silverman MG, et al. Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Qual Outcomes 2014;7:453-60.
17. McEvoy JW, Martin SS, Dardari ZA, Miedema MD, Sandfort V, Yeboah J, et al. Coronary artery calcium to guide a personalized risk-based approach to initiation and intensification of antihypertensive therapy. Circulation 2017;135: 153-65.
18. Reis JP, Loria CM, Lewis CE, Powell-Wiley TM, Wei GS, Carr JJ, et al. Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age. JAMA 2013;310: 280-8.
19. Nasir K, Rubin J, Blaha MJ, Shaw LJ, Blankstein R, Rivera JJ, et al. Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals. Circ Cardiovasc Imaging 2012; 5:467-73.
20. Carr J, Jacobs DR Jr, Terry JG, Shay CM, Sidney CM, Liu K, et al. Association of coronary artery calcium in adults aged 32 to 46 years with incident coronary heart disease and death. JAMA Cardiol 2017 Feb 8 [Epub]. http://doi.org/10.1001/ jamacardio.2016.5493.
21. Blankstein R, Greenland P. Screening for coronary artery disease at an earlier age. JAMA Cardiol 2017 Feb 8 [Epub]. http://doi.org/10.1001/jamacardio.2016.5552.
22. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol 2005;46:166-72.
23. Gupta A, Varshney R, Lau E, Hulten E, Bittencourt MS, Blaha MJ, et al. The identification of coronary atherosclerosis is associated with initiation of pharmacologic and lifestyle preventive therapies: a systematic review and metaanalysis. Poster presented at: 2016 American College of Cardiology (ACC) 65th Annual Scientific Session and Expo; 2016 Apr 2-4; Chicago, IL.
24. Rozanski A, Gransar H, Shaw LJ, Kim J, Miranda-Peats L, Wong ND, et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol 2011;57:1622-32.
25. Orakzai RH, Nasir K, Orakzai SH, Kalia N, Gopal A, Musunuru K, et al. Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. Am J Cardiol 2008;101: 999-1002.
26. Kalia NK, Miller LG, Nasir K, Blumenthal RS, Agrawal N, Budoff MJ. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis 2006;185:394-9.
27. Taylor AJ, Bindeman J, Feuerstein I, Le T, Bauer K, Byrd C, et al. Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. J Am Coll Cardiol 2008;51:1337-41.
28. Nasir K, McClelland RL, Blumenthal RS, Goff DC Jr, Hoffmann U, Psaty BM, et al. Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications: the Multi-Ethnic Study of Atherosclerosis (MESA). Circ Cardiovasc Qual Outcomes 2010;3:228-35.
29. Schwartz J, Allison M, Wright CM. Health behavior modification after electron beam computed tomography and physician consultation. J Behav Med 2011;34:148-55.
30. O'Malley PG, Feuerstein IM, Taylor AJ. Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: a randomized controlled trial. JAMA 2003;289:2215-23.
31. Obuchowski NA, Holden D, Modic MT, Cheah G, Fu AZ, Brant-Zawadzki M, et al. Total-body screening: preliminary results of a pilot randomized controlled trial. J Am Coll Radiol 2007;4:604-11.
32. Lederman J, Ballard J, Njike VY, Margolies L, Katz DL. Information given to postmenopausal women on coronary computed tomography may influence cardiac risk reduction efforts. J Clin Epidemiol 2007;60:389-96.
33. Whelton SP, Nasir K, Blaha MJ, Gransar H, Metkus TS, Coresh J, et al. Coronary artery calcium and primary prevention risk assessment: what is the evidence? An updated meta-analysis on patient and physician behavior. Circ Cardiovasc Qual Outcomes 2012;5:601-7.
34. Mols RE, Jensen JM, Sand NP, Fuglesang C, Bagdat D, Vedsted P, et al. Visualization of coronary artery calcification: influence on risk modification. Am J Med 2015;128: 1023.e23-31.
35. Gibson AO, Blaha MJ, Arnan MK, Sacco RL, Szklo M, Herrington DM, et al. Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA study. JACC Cardiovasc Imaging 2014;7:1108-15.
36. Hermann DM, Gronewold J, Lehmann N, Moebus S, Jockel KH, Bauer M, et al. Coronary artery calcification is an independent stroke predictor in the general population. Stroke 2013;44:1008-13.
37. Bittencourt MS, Blankstein R, Mao S, Rivera JJ, Bertoni AG, Shaw LJ, et al. Left ventricular area on non-contrast cardiac computed tomography as a predictor of incident heart failure: the Multi-Ethnic Study of Atherosclerosis. J Cardiovasc Comput Tomogr 2016;10:500-6.
38. Kalsch H, Lehmann N, Mohlenkamp S, Neumann T, Slomiany U, Schmermund A, et al. Association of coronary artery calcium and congestive heart failure in the general population: results of the Heinz Nixdorf recall study. Clin Res Cardiol 2010;99:175-82.
39. O'Neal WT, Efird JT, Dawood FZ, Yeboah J, Alonso A, Heckbert SR, et al. Coronary artery calcium and risk of atrial fibrillation (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 2014;114:1707-12.
40. Handy CE, Desai CS, Dardari ZA, Al-Mallah MH, Miedema MD, Ouyang P, et al. The association of coronary artery calcium with noncardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging 2016; 9:568-76.
41. Rana JS, Liu JY, Moffet HH, Jaffe M, Karter AJ. Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events. J Gen Intern Med 2016;31:387-93.
42. Rana JS, Blankstein R. Are all individuals with diabetes equal, or some more equal than others? JACC Cardiovasc Imaging 2016;9:1289-91.
43. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 2009;301:1547-55.
44. Muhlestein JB, Lappe DL, Lima JA, Rosen BD, May HT, Knight S, et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA 2014;312:2234-43.
45. Malik S, Budoff MJ, Katz R, Blumenthal RS, Bertoni AG, Nasir K, et al. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the Multi-Ethnic Study of Atherosclerosis. Diabetes Care 2011;34:2285-90.